Hyperhidrosis most commonly affects the armpits, followed by the palms of the hands and the soles of the feet. Impairment of quality of life differs based on where primary hyperhidrosis manifests on ...
Ever slip inside your shoes because your feet are literally swimming in sweat? You’re not imagining things, and you’re definitely not alone. What you might be experiencing goes way beyond normal ...
Treatment of hyperhidrosis can be divided into topical, oral, surgical, and nonsurgical treatments (botulinum toxin). These therapeutic options differ with respect to their efficacy, duration of ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Tap water ...
Background: Recent studies demonstrate that botulinum toxin type A (BTX-A) decreases palmar hyperhidrosis. Objective: To evaluate the efficacy and safety of BTX-A for palmar hyperhidrosis. Methods: ...
SAN DIEGO, CA / ACCESSWIRE / January 4, 2024 / Dermata Therapeutics, Inc. (Nasdaq:DRMA, DRMAW) ("Dermata" or the "Company"), a late-stage biotechnology company focusing on the treatment of medical and ...
Bergón-Sendín M, Pulido-Pérez A, Sáez-Martín LC et al. (2016) Preliminary experience with transdermal oxybutynin patches for hyperhidrosis. Actas Dermosifiliogr 107(10), 845–50 Costa Jr. AS, Leão LEV, ...
- This is the Company's second granted patent for DMT410, using its Spongilla technology to topically deliver botulinum toxin for hyperhidrosis - - The Company recently entered into a Clinical Trial ...
Bergon-Sendin M, Pulido-Perez A, Saez-Martin L C et al. (2016) Preliminary experience with transdermal oxybutynin patches for hyperhidrosis. Actas Dermo-Sifiliograficas 107(10), 845–50 Study not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback